Summary of Significant Accounting Policies (Tables)
|
6 Months Ended |
Jun. 30, 2022 |
| Disclosure of Summary of Significant Accounting Policies [Abstract] |
|
| Schedule of recognition, measurement, presentation and disclosure of financial instruments |
| | |
June
30,
2022 | | |
December 31,
2021 | |
| Cash and cash
equivalents | |
$ | 48,929,895 | | |
$ | 53,317,405 | |
| Restricted
cash | |
| 223,522 | | |
| 233,872 | |
| Total
cash, cash equivalents and restricted cash | |
$ | 49,153,417 | | |
$ | 53,551,277 | |
|
| Schedule of marketable securities |
| |
Amortized
Cost | | |
Gross
Unrealized
Losses | | |
Gross
Unrealized
Gains | | |
Fair
Value | |
| June 30, 2022: | |
| | |
| | |
| | |
| |
| Money Market Funds included in
Cash Equivalents | |
$ | 6,950,998 | | |
$ | (695 | ) | |
$ | - | | |
$ | 6,950,303 | |
| U.S. Government Agency Securities | |
| 9,122,516 | | |
| (14,117 | ) | |
| - | | |
| 9,108,399 | |
| Corporate Securities | |
| 4,015,563 | | |
| (17,398 | ) | |
| - | | |
| 3,998,165 | |
| Commercial Paper | |
| 2,594,919 | | |
| (8,935 | ) | |
| - | | |
| 2,585,984 | |
| Subtotal | |
| 15,732,998 | | |
| (40,450 | ) | |
| - | | |
| 15,692,548 | |
| Total June 30, 2022 | |
$ | 22,683,996 | | |
$ | (41,145 | ) | |
$ | - | | |
$ | 22,642,851 | |
| December 31, 2021: | |
| | | |
| | | |
| | | |
| | |
| Money Market Funds included in Cash Equivalents | |
$ | 10,462,877 | | |
$ | (23 | ) | |
$ | - | | |
$ | 10,462,854 | |
| U.S. Government Agency Securities | |
| 2,806,597 | | |
| (1,261 | ) | |
| - | | |
| 2,805,336 | |
| Corporate Securities | |
| 7,548,493 | | |
| (4,467 | ) | |
| 1 | | |
| 7,544,027 | |
| Commercial Paper | |
| 1,799,548 | | |
| - | | |
| 92 | | |
| 1,799,640 | |
| Subtotal | |
| 12,154,638 | | |
| (5,728 | ) | |
| 93 | | |
| 12,149,003 | |
| Total December 31, 2021 | |
$ | 22,617,515 | | |
$ | (5,751 | ) | |
$ | 93 | | |
$ | 22,611,857 | |
|
| Schedule of fair value on a recurring basis |
| |
Carrying
Value | | |
Level
1 | | |
Level
2 | | |
Level
3 | |
| June 30, 2022: | |
| | |
| | |
| | |
| |
| Money
Market Funds and Cash Equivalents | |
$ | 6,950,303 | | |
$ | 6,950,303 | | |
$ | - | | |
$ | - | |
| U.S. Government Agency
Securities | |
| 9,108,399 | | |
| 9,108,399 | | |
| - | | |
| | |
| Corporate Securities | |
| 3,998,165 | | |
| - | | |
| 3,998,165 | | |
| - | |
| Commercial
Paper | |
| 2,585,984 | | |
| - | | |
| 2,585,984 | | |
| - | |
| Subtotal | |
| 15,692,548 | | |
| 9,108,399 | | |
| 6,584,149 | | |
$ | - | |
| Total June 30, 2022 | |
$ | 22,642,851 | | |
$ | 16,058,702 | | |
$ | 6,584,149 | | |
$ | - | |
| December 31, 2021: | |
| | | |
| | | |
| | | |
| | |
| Money
Market Funds and Cash Equivalents | |
$ | 10,462,854 | | |
$ | 10,462,854 | | |
$ | - | | |
$ | - | |
| U.S.
Government Agency Securities | |
| 2,805,336 | | |
| 2,805,336 | | |
| - | | |
| | |
| Corporate
Securities | |
| 7,544,027 | | |
| - | | |
| 7,544,027 | | |
| - | |
| Commercial
Paper | |
| 1,799,640 | | |
| - | | |
| 1,799,640 | | |
| - | |
| Subtotal | |
| 12,149,003 | | |
| 2,805,336 | | |
| 9,343,667 | | |
| - | |
| Total
December 31, 2021 | |
$ | 22,611,857 | | |
$ | 13,268,190 | | |
$ | 9,343,667 | | |
$ | - | |
|
| Schedule of Inventories |
| | |
June
30,
2022 | | |
December 31,
2021 | |
| Finished
goods | |
$ | 1,720 | | |
$ | 3,008 | |
|
| Schedule of accrued expenses |
| | |
June
30,
2022 | | |
December 31,
2021 | |
| Professional
and consulting fees | |
$ | 589,885 | | |
$ | 311,408 | |
| Accrued payroll and payroll
taxes | |
| 1,787,260 | | |
| 2,508,398 | |
| Manufacturing development
related | |
| 186,539 | | |
| 99,614 | |
| Other | |
| 84,942 | | |
| 94,736 | |
| Total | |
$ | 2,648,626 | | |
$ | 3,014,156 | |
|
| Schedule of diluted net loss per share |
| | |
Six
Months Ended June 30, | |
| | |
2022 | | |
2021 | |
| | |
(Number
of Shares of Common Stock Issuable) | |
| Series C non-voting
preferred stock | |
| 4,000 | | |
| 4,000 | |
| Series E non-voting preferred
stock | |
| 391,953 | | |
| 391,953 | |
| Series G non-voting preferred
stock | |
| 5,004,069 | | |
| 5,004,069 | |
| Shares issuable for payment
of deferred board compensation | |
| 48,909 | | |
| 48,909 | |
| Shares underlying outstanding
warrants | |
| 56,455 | | |
| 56,455 | |
| Shares underlying outstanding
stock options | |
| 4,433,285 | | |
| 3,765,746 | |
| Restricted
stock units | |
| 207,469 | | |
| - | |
| Total
potentially dilutive shares | |
| 10,146,140 | | |
| 9,271,132 | |
|